These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8026738)
1. Effects of some quinolones on imipenem-induced seizures in DBA/2 mice. De Sarro A; Ammendola D; De Sarro G Gen Pharmacol; 1994 Mar; 25(2):369-79. PubMed ID: 8026738 [TBL] [Abstract][Full Text] [Related]
2. Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. De Sarro A; Zappalá M; Chimirri A; Grasso S; De Sarro GB Antimicrob Agents Chemother; 1993 Jul; 37(7):1497-503. PubMed ID: 8395790 [TBL] [Abstract][Full Text] [Related]
3. Effects of novel 6-desfluoroquinolones and classic quinolones on pentylenetetrazole-induced seizures in mice. De Sarro A; Cecchetti V; Fravolini V; Naccari F; Tabarrini O; De Sarro G Antimicrob Agents Chemother; 1999 Jul; 43(7):1729-36. PubMed ID: 10390231 [TBL] [Abstract][Full Text] [Related]
4. [Drug interactions between nonsteroidal anti-inflammatory drug and pazufloxacin mesilate, a new quinolone antibacterial agent for intravenous use: convulsions in mice after intravenous or intracerebroventricular administration]. Fukuda H; Kawamura Y Jpn J Antibiot; 2002 Jun; 55(3):270-80. PubMed ID: 12199111 [TBL] [Abstract][Full Text] [Related]
5. Comparative convulsant potencies of two carbapenem derivatives in C57 and DBA/2 mice. de Sarro A; Imperatore C; Mastroeni P; de Sarro G J Pharm Pharmacol; 1995 Apr; 47(4):292-6. PubMed ID: 7791026 [TBL] [Abstract][Full Text] [Related]
6. Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice. De Sarro G; Nava F; Calapai G; De Sarro A Antimicrob Agents Chemother; 1997 Feb; 41(2):427-34. PubMed ID: 9021202 [TBL] [Abstract][Full Text] [Related]
7. Effects of some excitatory amino acid antagonists on imipenem-induced seizures in DBA/2 mice. De Sarro G; Ammendola D; Nava F; De Sarro A Brain Res; 1995 Feb; 671(1):131-40. PubMed ID: 7728525 [TBL] [Abstract][Full Text] [Related]
8. Comparative epileptogenic properties of two monobactam derivatives in C57, Swiss and DBA/2 mice. De Sarro A; Naccari F; Imperatore C; De Sarro GB J Antimicrob Chemother; 1996 Sep; 38(3):475-84. PubMed ID: 8889722 [TBL] [Abstract][Full Text] [Related]
10. Assessment of temafloxacin neurotoxicity in rodents. Giardina WJ Am J Med; 1991 Dec; 91(6A):42S-44S. PubMed ID: 1662895 [TBL] [Abstract][Full Text] [Related]
11. Responsiveness of genetically epilepsy-prone rats to aminophylline-induced seizures and interactions with quinolones. De Sarro A; De Sarro GB Neuropharmacology; 1991 Feb; 30(2):169-76. PubMed ID: 1851545 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of new quinolones on GABA(A) receptor-mediated response and its potentiation with felbinac in Xenopus oocytes injected with mouse-brain mRNA: correlation with convulsive potency in vivo. Kawakami J; Yamamoto K; Asanuma A; Yanagisawa K; Sawada Y; Iga T Toxicol Appl Pharmacol; 1997 Aug; 145(2):246-54. PubMed ID: 9266796 [TBL] [Abstract][Full Text] [Related]
13. Interaction of the new quinolone antibacterial agent levofloxacin with fenbufen in mice. Furuhama K; Akahane K; Tawara K; Takayama S Arzneimittelforschung; 1992 Mar; 43(3A):406-8. PubMed ID: 1622442 [TBL] [Abstract][Full Text] [Related]
14. Correlation between in vitro and in vivo models of proconvulsive activity with the carbapenem antibiotics, biapenem, imipenem/cilastatin and meropenem. Day IP; Goudie J; Nishiki K; Williams PD Toxicol Lett; 1995 Apr; 76(3):239-43. PubMed ID: 7762010 [TBL] [Abstract][Full Text] [Related]
15. [Modulation by quinolones of the in vitro proliferative response of splenic cells of the mouse and IL 1 production]. Guenounou M; Ronco E; Kodari E; Vacheron F; Momrikof V Pathol Biol (Paris); 1987 Jun; 35(5 Pt 2):785-9. PubMed ID: 3309816 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic-pharmacodynamic contributions to the convulsant activity of pefloxacin and norfloxacin in rats. Delon A; Huguet F; Courtois P; Vierfond JM; Bouquet S; Couet W J Pharmacol Exp Ther; 1997 Feb; 280(2):983-7. PubMed ID: 9023315 [TBL] [Abstract][Full Text] [Related]
17. Pharmacological evaluation of garenoxacin, a novel des-F(6)-quinolone antimicrobial agent: effects on the central nervous system. Nakamura T; Fukuda H; Morita Y; Soumi K; Kawamura Y J Toxicol Sci; 2003 Feb; 28(1):35-45. PubMed ID: 12696183 [TBL] [Abstract][Full Text] [Related]
18. Frequency and expression of mutational resistance to the 4-quinolone antibacterials. Smith JT Scand J Infect Dis Suppl; 1986; 49():115-23. PubMed ID: 3547618 [TBL] [Abstract][Full Text] [Related]
19. Effects of anti-inflammatory drugs on convulsant activity of quinolones: a comparative study of drug interaction between quinolones and anti-inflammatory drugs. Hori S; Kizu J; Kawamura M J Infect Chemother; 2003 Dec; 9(4):314-20. PubMed ID: 14691652 [TBL] [Abstract][Full Text] [Related]
20. Structural features resulting in convulsive activity of carbapenem compounds: effect of C-2 side chain. Sunagawa M; Matsumura H; Sumita Y; Nouda H J Antibiot (Tokyo); 1995 May; 48(5):408-16. PubMed ID: 7797443 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]